Paeoniae decoction attenuates chronic colitis-associated intestinal fibrosis by suppressing TGF-β/Smad-mediated epithelial-mesenchymal transition and remodeling the metabolic microenvironment
Journal of Ethnopharmacology · 2026
DOI: 10.1016/j.jep.2026.122091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026. Verfasst von Meng Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Colitis, Paeonia, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Paeoniae Decoction (PD) is a classic Chinese medicine formula for treating intestinal diseases. However, its direct intervention effect on intestinal fibrosis and the underlying molecular mechanisms have not been fully elucidated. AIM OF THE STUDY: To evaluate the effect of PD on inflammatory bowel disease (IBD) associated intestinal fibrosis and to systematically investigate its potential molecular mechanisms utilizing integrated multi-omics. MATERIALS AND METHODS: The chemical constituents of PD were characterized and quantified utilizing ultra-high performance liquid chromatography-Quadrupole-Orbitrap mass spectrometry (LC-Q-Orbitrap-MS) and LC-MS/MS. A chronic experimental colitis-associated intestinal fibrosis mouse model lasting 56 days and involving four repeated cycles of dextran sulfate sodium (DSS) injury was established. The therapeutic efficacy of PD was evaluated through endoscopy, histopathological analysis, and collagen staining. Label-free quantitative proteomics and untargeted metabolomics and network pharmacology were employed to elucidate the target networks. In vitro mechanisms were further validated in TGF-β1-stimulated NCM460 cells using wound healing assays, immunofluorescence, and Western blotting to evaluate the epithelial-mesenchymal transition (EMT) process and the TGF-β/Smad signaling pathway. Finally, molecular docking was used to verify the direct binding of the main bioactive components of PD to the key pathway targets. RESULTS: Chemical profiling identified 16 common constituents across independent batches of PD. In vivo, PD administration significantly ameliorated intestinal fibrosis and reduced massive extracellular matrix (ECM) deposition in the mucosal and submucosal layers. Integrated omics analyses revealed that PD profoundly modulated the TGF-β signaling pathway, ECM-receptor interaction, and the Sphingolipid signaling pathway. Mechanistically, PD dose-dependently inhibited myofibroblast activation, downregulating the expression of α-SMA, Vimentin, Collagen I, and Collagen III. In vitro, PD serum suppressed TGF-β1-induced cell migration, preserved the epithelial marker E-cadherin, and inhibited the nuclear translocation of Snail by significantly decreasing the phosphorylation of Smad2 and Smad3. Furthermore, PD reversed pro-fibrotic sphingolipid metabolism and upregulated taurine and glutathione metabolism associated with antioxidant defense. CONCLUSION: PD effectively alleviates chronic colitis-associated intestinal fibrosis by inhibiting the TGF-β/Smad signaling pathway-mediated EMT process, reducing ECM deposition, and reprogramming the fibrotic metabolic microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: wangqing@gzucm.edu.cn.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: luoxia@gzucm.edu.cn.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Electronic address: zl@gzucm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Zhao, M., Yi, Q., Liang, J., Li, C., Ke, X., Zhao, Y., Shi, Y., Deng, S., Wang, Q., Luo, X., & Zhou, L. (2026). Paeoniae decoction attenuates chronic colitis-associated intestinal fibrosis by suppressing TGF-β/Smad-mediated epithelial-mesenchymal transition and remodeling the metabolic microenvironment. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2026.122091
Vancouver
Zhao M, Yi Q, Liang J, Li C, Ke X, Zhao Y, et al. Paeoniae decoction attenuates chronic colitis-associated intestinal fibrosis by suppressing TGF-β/Smad-mediated epithelial-mesenchymal transition and remodeling the metabolic microenvironment. Journal of Ethnopharmacology. 2026. doi:10.1016/j.jep.2026.122091
BibTeX
@article{Zhao2026,
author = {Zhao, Meng and Yi, Qi and Liang, Jieyin and Li, Chunjing and Ke, Xuezhou and Zhao, Yijia and Shi, Yuan and Deng, Siliang and Wang, Qing and Luo, Xia and Zhou, Lian},
title = {Paeoniae decoction attenuates chronic colitis-associated intestinal fibrosis by suppressing TGF-β/Smad-mediated epithelial-mesenchymal transition and remodeling the metabolic microenvironment},
journal = {Journal of Ethnopharmacology},
year = {2026},
doi = {10.1016/j.jep.2026.122091}
}
EUVIMED